Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort descending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort descending Site Location Division Business Functional Area Date Posted
Sr. Procurement Specialist, TPRM Hyderabad (Office) India Operations CTS Procurement Jul 23, 2024
Sr. Spec. Cloud Infrastructure Solution Delivery - Global Drug Development INSURGENTES Mexico Operations CTS Technology Transformation Oct 22, 2024
Sr. Spec. DDIT GF Sol.Del. HCM Hyderabad (Office) India Operations CTS Technology Transformation Oct 10, 2024
Sr. Spec. DDIT IES Cloud Engineering Hyderabad (Office) India Operations CTS Technology Transformation May 09, 2024
Sr. Spec. DDIT IES Cloud Engineering Hyderabad (Office) India Operations CTS Technology Transformation May 09, 2024
Sr. Spec. DDIT IES Cloud Engineering Hyderabad (Office) India Operations CTS Technology Transformation Apr 16, 2024
Sr. Spec. DDIT IES Cloud Engineering Hyderabad (Office) India Operations CTS Technology Transformation Oct 11, 2024
Sr. Spec. DDIT IES Database Services INSURGENTES Mexico Operations CTS Technology Transformation Aug 27, 2024
Sr. Spec. DDIT IES DB & MW Services-IES- Cloud Platform Svcs Hyderabad (Office) India Operations CTS Technology Transformation Sep 19, 2024
Sr. Spec. DDIT IES NetSec Engg Hyderabad (Office) India Operations CTS Technology Transformation Apr 16, 2024
Sr. Spec. DDIT IES NW Engineering Hyderabad (Office) India Operations CTS Technology Transformation Apr 22, 2024
Sr. Spec. DDIT IES O365 Sec. & Compl. Hyderabad (Office) India Operations CTS Technology Transformation Oct 09, 2024
Sr. Spec. DDIT IES Projects Hyderabad (Office) India Operations CTS Technology Transformation Oct 10, 2024
Sr. Spec. DDIT IES Projects Hyderabad (Office) India Operations CTS Technology Transformation Oct 10, 2024
Sr. Spec. DDIT IES Solution Delivery INSURGENTES Mexico Operations CTS Technology Transformation Oct 03, 2024
Sr. Spec. DDIT IES Supplier Management Hyderabad (Office) India Operations CTS Information Technology Oct 18, 2024
Sr. Spec. DDIT IES Workforce Mgmt. Hyderabad (Office) India Operations CTS Technology Transformation Oct 03, 2024
Sr. Spec. DDIT ISC Gov GxP Assessments Hyderabad (Office) India Operations CTS Technology Transformation Oct 18, 2024
Sr. Spec. DDIT ISC Gov SOX IT Method Hyderabad (Office) India Operations CTS Technology Transformation Sep 20, 2024
Sr. Spec. DDIT ISC IES Hyderabad (Office) India Operations CTS Technology Transformation May 21, 2024
Sr. Spec. DDIT ISC QNova Hyderabad (Office) India Operations CTS Technology Transformation Sep 24, 2024
Sr. Spec. DDIT ISC SecOps Cyber Tools Hyderabad (Office) India Operations CTS Technology Transformation May 07, 2024
Sr. Spec. DDIT ISC SecOps IAM Hyderabad (Office) India Operations CTS Technology Transformation Apr 17, 2024
Sr. Spec. IT Solution Delivery INSURGENTES Mexico Operations CTS Information Technology Jul 15, 2024
Sr. Special. DDIT IES O365 eDLS Ops Hyderabad (Office) India Operations CTS Technology Transformation May 29, 2024
Sr. Specialist (SAP Business Process Automation) Hyderabad (Office) India Operations CTS Technology Transformation Oct 23, 2024
Sr. Specialist DDIT APD ERP PlatformTech Hyderabad (Office) India Operations CTS Technology Transformation Apr 23, 2024
Sr. Specialist DDIT ISC CSOC Engineering Prague Czech Republic Operations CTS Technology Transformation Oct 23, 2024
Sr. Specialist DDIT ISC CSOC Engineering Hyderabad (Office) India Operations CTS Technology Transformation Oct 07, 2024
Sr. Specialist DDIT ISC CSOC Engineering INSURGENTES Mexico Operations CTS Technology Transformation Sep 26, 2024
Sr. Specialist DDIT ISC Detection & Response Hyderabad (Office) India Operations CTS Technology Transformation Oct 17, 2024
Sr. Specialist Qualification Engineer INSURGENTES Mexico Operations CTS Technology Transformation Sep 11, 2024
Sr. Specialist Quality Management Hyderabad (Office) India Operations CTS Technology Transformation Oct 21, 2024
Sr. TA Strategy Lead (Renal Therapy Area) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Aug 07, 2024
Sr.Spec.DDIT ISC Gov Indep.Control Asses Hyderabad (Office) India Operations CTS Technology Transformation Sep 18, 2024
Sr.Specialist – Wireless Network Engineering INSURGENTES Mexico Operations CTS Technology Transformation Jul 16, 2024
Sr.Territory Business Executive Madhya Pradesh India International Innovative Medicines Sales Oct 03, 2024
SSO Feasibility Manager Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 21, 2024
SSO Finance Specialist İstanbul Kavacık Turkey Development Innovative Medicines Research & Development Sep 10, 2024
SSO Finance Specialist Shanghai (Shanghai) China Development Innovative Medicines Research & Development Oct 20, 2024
SSO Site Partnership Manager Guangzhou (Guangdong Province) China Development Innovative Medicines Research & Development Sep 17, 2024
SSO Study Start-Up Manager Mapletree Business City (MBC) Singapore Development Innovative Medicines Research & Development Oct 21, 2024
SSU Manager INSURGENTES Mexico Development Innovative Medicines Research & Development Oct 15, 2024
Strategic Design Commercial Contracts Manager Barcelona Gran Vía Spain Operations CTS Marketing Sep 24, 2024
Strategy Director, Clinical Development Basel (City) Switzerland Development Innovative Medicines Research & Development Oct 17, 2024
Strategy Manager Taipei Taiwan International Innovative Medicines Marketing Oct 22, 2024
Study Leader Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Sep 05, 2024
Study Start Up Senior Lead Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Oct 18, 2024
Study Start-Up Clinical Research Associate Mapletree Business City (MBC) Singapore Development Innovative Medicines Research & Development Oct 21, 2024
Study Start-Up Lead Shanghai (Shanghai) China Development Innovative Medicines Research & Development Oct 22, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only